… , CD80, and CD86 in aggressive pituitary adenoma samples provide a rationale for studying
… for tumor control. Lin et al. attributed the response of a corticotroph pituitary carcinoma to …

… Pituitary carcinomas (PC) are very rare clinical entities with an incidence of 0.1 to 0.2% of
pituitary tumors … -secreting, followed by ACTH-secreting adenomas. Fifteen to twenty percent of …

… behavior of pituitary tumor (invasiveness linked to a higher risk of recurrence) and may open
up new strategies for the early identification and management of the most aggressive forms. …

… Pituitary adenomas can show a tendency to grow, despite multimodal treatment. Temozolomide
(TMZ) has been used in the last 15 years in patients with aggressive pituitary tumors. …

… in DNA methylation has been observed in many types of human cancers; moreover, it has
been proved to correlate with worse patient prognosis and more aggressive cancer growth. …

… for pituitary carcinomas and aggressive pituitary tumors. … one corticotroph carcinoma and
one aggressive corticotroph tumor … option for aggressive pituitary tumors and carcinomas. The …

… The next important step will be to relinquish the term “pituitary carcinoma” for metastatic …
malignancies such as small and large cell neuroendocrine carcinomas [2], this terminology is …

… useful drug for the management of aggressive pituitary adenomas. Pituitary adenoma (PA) is
the … [ 32 ] Most pituitary carcinomas secrete either ACTH or prolactin. Near-total resection or …

… of pituitary adenomas and pituitary carcinomas. For didactic reasons, the terms … Pituitary
adenomas are incidental findings in up to 20% of autopsies. The majority of adenomas are …

… We evaluated dural invasion as a putative marker of aggressive pituitary adenoma growth.
Reported rates of dural invasion vary widely and may partly reflect the lack of a standard for …